Shire is seeking approval of lisdexamfetamine dimesylate in the form of a chewable tablet (vyvanse chewable tablet) for the treatment of attention deficit hyperactive disorder (adhd). Dec 25, 2024 · vyvanse may cause new or worsening psychosis (unusual thoughts or behavior), especially if you have a history of depression, mental illness, or bipolar disorder. Jan 21, 2025 · sun pharma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Takeda has vyvanse available. Teva has lisdexamfetamine capsules.
Briefing materials for the september 15, 2020, meeting of the pediatric advisory committee.
Will Anonib AI Replace You? Find Out Now.
The Untold Story Of The Karely Ruiz Leak
Aroomikim: A Story Of Resilience